Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 4/2016

01-04-2016 | Original Article

Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study

Authors: M. L. Avila, E. Pullenayegum, S. Williams, A. Shammas, J. Stimec, E. Sochett, K. Marr, L. R. Brandão

Published in: Osteoporosis International | Issue 4/2016

Login to get access

Abstract

Summary

We studied bone mineral density (BMD) of children exposed to long-term warfarin. BMD Z-scores ≤ −2.0 were estimated to occur in less than one fifth of the patients after 10 years of warfarin exposure, and BMI and growth hormone deficiency predicted BMD changes over time. These predictors can help identify high-risk patients.

Introduction

Children with chronic diseases are at increased risk of developing thrombosis, which may require long-term warfarin therapy. Warfarin could further jeopardize the bone health of a population already at risk for bone fragility. Our objective was to investigate the occurrence and timing of low bone mineral density (BMD) and the predictors that influence BMD trajectory in children receiving warfarin for >1 year.

Methods

We analyzed the results of an institutional protocol that includes dual-energy X-ray absorptiometry, with or without spinal X-rays and laboratory biomarkers, as required.

Results

Low BMD (age, sex, race, and height-for-age-Z-score adjusted BMD Z-score ≤ −2.0) was detected in 13 % (9/70) of the patients at some point during their follow-up; these patients were more likely to have complex underlying medical conditions and low body mass index (BMI) percentile. BMD Z-scores remained within normal range in 87 % of children. Survival analysis showed that the estimated 10-year abnormal BMD-free rate for the entire group was 81 % (95 % confidence interval [CI] 69 to 93 %). Trajectory analysis revealed that BMI percentiles at baseline and growth hormone deficiency (GHD) were associated with lower BMD Z-scores at the first assessment, whereas baseline BMI percentile was the only predictor of BMD Z-score over time.

Conclusions

Our findings identified BMI and GHD as risk factors influencing BMD in children exposed to long-term warfarin, creating an opportunity for early detection and intervention in these patients.
Literature
1.
Daly RM, Petit MA (2007) Optimizing bone mass and strength the role of physical activity and nutrition during growth. Medicine and sport science. Karger, Basel ; New York, pp x, 162 p
2.
Bonjour JP, Theintz G, Law F, Slosman D, Rizzoli R (1994) Peak bone mass. Osteoporos Int J Established Result Coop Between Eur Found Osteoporosis Natl Osteoporosis Found USA 4(Suppl 1):7–13CrossRef
3.
Glorieux FH, Pettifor JM, Jüppner H (2012) Pediatric bone biology & diseases, 2nd edn. Elsevier/Academic Press, Amsterdam, pp xiii, 853 p., [816] p. of col. plates
4.
Hernandez CJ, Beaupre GS, Carter DR (2003) A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int J Established Result Coop Between Eur Found Osteoporosis Natl Osteoporosis Found USA 14:843–847CrossRef
5.
Streif W, Andrew M, Marzinotto V, Massicotte P, Chan AK, Julian JA, Mitchell L (1999) Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 94:3007–3014PubMed
6.
Doyle JJ, Koren G, Cheng MY, Blanchette VS (1988) Anticoagulation with sodium warfarin in children: effect of a loading regimen. J Pediatr 113:1095–1097CrossRefPubMed
7.
Poundarik AA, Diab T, Sroga GE, Ural A, Boskey AL, Gundberg CM, Vashishth D (2012) Dilatational band formation in bone. Proc Natl Acad Sci U S A 109:19178–19183CrossRefPubMedPubMedCentral
8.
Booth SL, Centi A, Smith SR, Gundberg C (2013) The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol 9:43–55CrossRefPubMed
9.
Shaul WL, Emery H, Hall JG (1975) Chondrodysplasia punctata and maternal warfarin use during pregnancy. Am J Dis Child 129:360–362PubMed
10.
Becker MH, Genieser NB, Finegold M, Miranda D, Spackman T (1975) Chondrodysplasis punctata: is maternal warfarin therapy a factor? Am J Dis Child 129:356–359CrossRefPubMed
11.
Pettifor JM, Benson R (1975) Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86:459–462CrossRefPubMed
12.
Pearson DA (2007) Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr 22:517–544CrossRef
13.
Mamdani M, Upshur RE, Anderson G, Bartle BR, Laupacis A (2003) Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 23:1–4CrossRefPubMed
14.
Jamal SA, Browner WS, Bauer DC, Cummings SR (1998) Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 128:829–832CrossRefPubMed
15.
Pilon D, Castilloux AM, Dorais M, LeLorier J (2004) Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf 13:289–294CrossRefPubMed
16.
Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 166:241–246CrossRefPubMed
17.
Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O'Fallon WM, Castro MR, Melton LJ 3rd (1999) Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 159:1750–1756CrossRefPubMed
18.
Barnes C, Newall F, Ignjatovic V, Wong P, Cameron F, Jones G, Monagle P (2005) Reduced bone density in children on long-term warfarin. Pediatr Res 57:578–581CrossRefPubMed
19.
Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S (2008) Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J Pediatr Hematol Oncol 30:592–597CrossRefPubMed
20.
Cheung AM, Halton J, Dinyari M, Chan A, Shaughnessy S, Webber C, Massicotte MP (2001) Bone Mineral Density (BMD) in a Cohort of Children on Long Term Wafarin Therapy. J Thromb Haemost OC1729
21.
Bendaly EA, DiMeglio LA, Fadel WF, Hurwitz RA (2015) Bone density in children with single ventricle physiology. Pediatr Cardiol 36:779–785CrossRefPubMed
22.
Bianchi ML, Leonard MB, Bechtold S et al (2014) Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions. J Clin Densitom Off J Int Soc Clin Densitom 17:281–294CrossRef
23.
Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM, International Society for Clinical D (2014) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom Off J Int Soc Clin Densitom 17:225–242CrossRef
24.
Zemel BS, Kalkwarf HJ, Gilsanz V et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96:3160–3169CrossRefPubMedPubMedCentral
25.
Zemel BS, Leonard MB, Kelly A et al (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95:1265–1273CrossRefPubMedPubMedCentral
26.
Bishop N, Arundel P, Clark E, Dimitri P, Farr J, Jones G, Makitie O, Munns CF, Shaw N, International Society of Clinical D (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions. J Clin Densitom Off J Int Soc Clin Densitom 17:275–280CrossRef
27.
Singer JD, Willett JB (2003) Applied longitudinal data analysis modeling change and event occurrence. Oxford University Press, [S.l.]
28.
Rego C, Guerra A, Guardiano M, Esteves P, Pereira J, Aguiar A, Areias JC (2002) Bony density in adolescents after surgical repair of tetralogy of fallot: a comparative study with healthy adolescents. Cardiol Young 12:531–536CrossRefPubMed
29.
Witzel C, Sreeram N, Coburger S, Schickendantz S, Brockmeier K, Schoenau E (2006) Outcome of muscle and bone development in congenital heart disease. Eur J Pediatr 165:168–174CrossRefPubMed
30.
Avitabile CM, Goldberg DJ, Zemel BS, Brodsky JL, Dodds K, Hayden-Rush C, Whitehead KK, Goldmuntz E, Rychik J, Leonard MB (2015) Deficits in bone density and structure in children and young adults following Fontan palliation. Bone 77:12–16CrossRefPubMedPubMedCentral
31.
Mayranpaa MK, Makitie O, Kallio PE (2010) Decreasing incidence and changing pattern of childhood fractures: a population-based study. J Bone Miner Res 25:2752–2759CrossRefPubMed
32.
Cooper C, Dennison EM, Leufkens HG, Bishop N, van Staa TP (2004) Epidemiology of childhood fractures in Britain: a study using the general practice research database. J Bone Miner Res 19:1976–1981CrossRefPubMed
33.
Landin LA (1983) Fracture patterns in children. Analysis of 8,682 fractures with special reference to incidence, etiology and secular changes in a Swedish urban population 1950–1979. Acta Orthop Scand Suppl 202:1–109PubMed
34.
Clark EM, Ness AR, Tobias JH (2008) Vigorous physical activity increases fracture risk in children irrespective of bone mass: a prospective study of the independent risk factors for fractures in healthy children. J Bone Miner Res 23:1012–1022CrossRefPubMedPubMedCentral
35.
Garn SM, Guzman MA, Wagner B (1969) Subperiosteal gain and endosteal loss in protein-calorie malnutrition. Am J Phys Anthropol 30:153–155CrossRefPubMed
36.
Garn SM, Rohmann CG, Behar M, Viteri F, Guzman MA (1964) Compact bone deficiency in protein-calorie malnutrition. Science 145:1444–1445CrossRefPubMed
37.
Bass SL, Eser P, Daly R (2005) The effect of exercise and nutrition on the mechanostat. J Musculoskelet Neuronal Interact 5:239–254PubMed
38.
Stettler N, Berkowtiz RI, Cronquist JL, Shults J, Wadden TA, Zemel BS, Leonard MB (2008) Observational study of bone accretion during successful weight loss in obese adolescents. Obesity 16:96–101CrossRefPubMed
39.
Leonard MB, Shults J, Wilson BA, Tershakovec AM, Zemel BS (2004) Obesity during childhood and adolescence augments bone mass and bone dimensions. Am J Clin Nutr 80:514–523CrossRefPubMed
40.
Wetzsteon RJ, Petit MA, Macdonald HM, Hughes JM, Beck TJ, McKay HA (2008) Bone structure and volumetric BMD in overweight children: a longitudinal study. J Bone Miner Res 23:1946–1953CrossRefPubMed
41.
Ducher G, Bass SL, Naughton GA, Eser P, Telford RD, Daly RM (2009) Overweight children have a greater proportion of fat mass relative to muscle mass in the upper limbs than in the lower limbs: implications for bone strength at the distal forearm. Am J Clin Nutr 90:1104–1111CrossRefPubMed
42.
Petit MA, Beck TJ, Shults J, Zemel BS, Foster BJ, Leonard MB (2005) Proximal femur bone geometry is appropriately adapted to lean mass in overweight children and adolescents. Bone 36:568–576CrossRefPubMed
43.
Vandewalle S, Taes Y, Van Helvoirt M et al (2013) Bone size and bone strength are increased in obese male adolescents. J Clin Endocrinol Metab 98:3019–3028CrossRefPubMed
44.
Klein KO, Larmore KA, de Lancey E, Brown JM, Considine RV, Hassink SG (1998) Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 83:3469–3475CrossRefPubMed
45.
Centers for Dsease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data (2007–2010) Prevalence of underweight among children and adolescents aged 2–19 years: Untited States, 1963–1965 through 2007–2010
46.
Public Health Agency of Canada (2011) The Health and Well-being of Canadian Youth and Young Adults. The Chief Public Health Officer's Reports on the State of Public Health in Canada Youth and Young Adults - Life in Transition
47.
Baxter JA, Al-Madhaki FI, Zlotkin SH (2014) Prevalence of malnutrition at the time of admission among patients admitted to a Canadian tertiary-care paediatric hospital. Paediatr Child Health 19:413–417CrossRefPubMedPubMedCentral
48.
Joosten KF, Hulst JM (2008) Prevalence of malnutrition in pediatric hospital patients. Curr Opin Pediatr 20:590–596CrossRefPubMed
49.
Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R (1990) Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 86:440–447PubMed
50.
Jagielska G, Wolanczyk T, Komender J, Tomaszewicz-Libudzic C, Przedlacki J, Ostrowski K (2002) Bone mineral density in adolescent girls with anorexia nervosa—a cross-sectional study. Eur Child Adolesc Psychiatry 11:57–62CrossRefPubMed
51.
Soyka LA, Misra M, Frenchman A, Miller KK, Grinspoon S, Schoenfeld DA, Klibanski A (2002) Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87:4177–4185CrossRefPubMed
52.
Misra M, Prabhakaran R, Miller KK et al (2008) Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 93:1231–1237CrossRefPubMed
53.
Misra M, Prabhakaran R, Miller KK et al (2008) Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab 93:1292–1297CrossRefPubMed
54.
Pichler J, Chomtho S, Fewtrell M, Macdonald S, Hill SM (2013) Growth and bone health in pediatric intestinal failure patients receiving long-term parenteral nutrition. Am J Clin Nutr 97:1260–1269CrossRefPubMed
55.
Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Makitie O (2014) Compromised peak bone mass in patients with inflammatory bowel disease—a prospective study. J Pediatr 164(1436–1443):e1431
56.
Lim LS, Benseler SM, Tyrrell PN, Harvey E, Herbert D, Charron M, Silverman ED (2012) Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients. Ann Rheum Dis 71:1686–1691CrossRefPubMed
57.
Hogler W, Shaw N (2010) Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol 72:281–289CrossRef
58.
Stochholm K, Christiansen JS (2011) The Epidemiology of Growth Hormone Deficiency. In Ho K (ed) Growth Hormone Related Diseases and Therapy. Springer
59.
McGowan A, Gibney J (2011) Issues in Long-Term Management of Adults with Growth Hormone Deficiency. In Ho K (ed) Growth Hormone Related Diseases and Therapy. Springer
Metadata
Title
Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study
Authors
M. L. Avila
E. Pullenayegum
S. Williams
A. Shammas
J. Stimec
E. Sochett
K. Marr
L. R. Brandão
Publication date
01-04-2016
Publisher
Springer London
Published in
Osteoporosis International / Issue 4/2016
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3411-8

Other articles of this Issue 4/2016

Osteoporosis International 4/2016 Go to the issue

Letter

Proton pump inhibitors and fracture risk: response to comments

Original Article

Regional and seasonal variations in ultraviolet B irradiation and vitamin D synthesis in India

Original Article

Association of osteoporosis with genetic variants of circadian genes in Chinese geriatrics

Original Article

Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis

Position Paper

The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations

Original Article

Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion